Surgeons raise concerns about Ozempic, other GLP-1s
Surgeons and health system leaders are voicing concerns about the unknown long-term risks of GLP-1 receptor agonists, such as Ozempic, Wegovy and Saxenda.
Source: beckershospitalreview.com
📰 Eli Lilly Byetta News
Eli Lilly Byetta News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eli Lilly Byetta. Real-time updates on events, politics, business and more.